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Background: In this study discussed the primary and regulatory roles of fatty acids, and investigated the affects of fatty
acids on metabolic programming.
Methods: Review of the literature was carried out on three electronic databases to assess the roles of fatty acids in
metabolic programming. All abstracts and full-text articles were examined, and the most relevant articles were selected
for screening and inclusion in this review.
Results: The mother’s nutritional environment during fetal period has important effects on long term health. Fatty acids
play a primary role in growth and development. Alterations in fatty acid intake in the fetal period may increase the risk
of obesity and metabolic disorders in later life. Maternal fatty acid intakes during pregnancy and lactation are passed to
the fetus and the newborn via the placenta and breast milk, respectively. Imbalances in fatty acid intake during the fetal
period change the fatty acid composition of membrane phospholipids, which can cause structural and functional
problems in cells. Additionally, the metabolic and neuroendocrine environments of the fetus and the newborn play key
roles in the regulation of energy balance.
Conclusions: Imbalances in fatty acid intake during pregnancy and lactation may result in permanent changes in
appetite control, neuroendocrine function and energy metabolism in the fetus, leading to metabolic programming.
Further studies are needed to determine the role of fatty acid intake in metabolic programming.
Keywords: Fatty acids, Fetal programming, Maternal nutritionBackground
Fatty acids take part in membrane phospholipids, and play
important roles in prenatal growth and development. Fatty
acids demonstrate their roles in cognitive and behavioral
development, and energy metabolism [1, 2]. Maternal nutri-
tional state affects fetal fatty acid supply to the fetus. Fatty
acids pass through the placenta during pregnancy, and they
are present in breast milk to fulfill their roles in postnatal
development [3, 4].
Changes in the metabolic environment, due to insuffi-
cient or excessive maternal nutrient intake, can cause short
and long-term implications for cell structure and function
[2]. Therefore, imbalances in fatty acid intake during fetal
development cause structural and functional changes in
metabolism [5].
In the fetal period, during organ development, changes in
the metabolic environment can lead to the development of
chronic diseases in later life [6]. During pregnancy,* Correspondence: seray.kabaran@emu.edu.tr
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increase the risk of a metabolic disorder in the fetus [7, 8].
Similarly, overeating during the postnatal stage also
increases the newborn’s risk of adulthood obesity
[7, 9]. Epidemiological and experimental studies have
shown that food substrates supplied to the fetus during
pregnancy and to the newborn immediately after birth,
can have long term health effects on the development of
metabolic diseases, including cardiovascular diseases,
type 2 diabetes, hypertension, and obesity [10–15].
One of the mechanisms associated with increasing the
risk of obesity is described as metabolic programming, due
to the consumption of excessive food during the fetal
period and after birth. Studies have shown that excessive
food intake by the mother during pregnancy can lead to
changes in the fetus’s appetite balance by causing perman-
ent changes in the central nervous system, and this causes
hyperphagia after birth [16–19].
Appetite control mechanisms in the hypothalamus have
an important effect on the development of chronic diseases.
The hypothalamus begins developing in an early stage of
pregnancy, and it continues to develop in postnatal life.ccess article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
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associated with the hypothalamus is important, and
changes in hormonal balance and nutrition status cause
changes in the development and function of the hypothal-
amus [6].
Fatty acids consumed for nutrition have vital functions
on energy metabolism and energy storage; they take part in
cell enlargement, promotion of cell functions, coordination
of intra- and extracellular communications, and regulation
of genes that supply energy substrates and control cellular
responses to the metabolic environment [20–22]. There-
fore, this review will discuss the primary and regulatory
roles of fatty acids, and it will explore the involvement of
fatty acids in metabolic programming.
Methods
Search strategy and selection of studies
To identify eligible studies for this rewiev, a computerized
search was performed for all publications available up to
March 2013 through PubMed, Web of Science, and
EMBASE databases using the following key words: ‘dietary
fatty acids’, ‘dietary lipids’, ‘omega-3 fatty acids’, ‘maternal high
fat diet’, ‘maternal fat intake’, ‘maternal obesity’, ‘fetal pro-
gramming’, metabolic programming’, ‘fetal origins of obesity’,
‘early life nutrition’, ‘maternal nutrition’, ‘hypothalamic pro-
gramming’, ‘developmental programming’, ‘placental lipid
transfer’, ‘maternal fatty acid transfer’ and ‘prenatal fatty acid
status.’ Reference lists from identified articles and relevant
reviews were examined for studies not indexed in the men-
tioned electronic databases. All abstracts and full-text arti-
cles were examined, and the most relevant articles were
selected for screening and inclusion in this review. The
search was limited to English literature.
Results
Fatty acids and growth and development
Long-chain, polyunsaturated fatty acids (LC-PUFA) are im-
portant compounds in cell membranes of the central ner-
vous system. Docosahexaenoic acid (DHA), which is found
in the brain and retinal membranes, regulates membrane
permeability, and improves receptor differentiation. DHA
levels also have an effect on enzyme activity [23]. Addition-
ally, DHA has important functions in immune processes,
like lymphocyte proliferation, natural killer cell activity, and
cytokine production. In addition, DHA and other LC-
PUFAs regulate inflammatory and immune responses [24].
The reported effects of omega-3 (n-3) fatty acids on birth
weight have turned attention to their effects on growth and
development. It was found that low birth weight (52–57 g
below average) was associated with the maternal low levels
of n-3 fatty acids and dihomo-gamma-linoleic acid (a pre-
cursor of arachidonic acid [AA]), but high levels of
omega-6 (n-6) fatty acids and trans fatty acids (elaidic
acid). Those results indicated that imbalanced maternalfatty acid intakes were associated with impairments in
fetal growth and development [25].
DHA is able to pass from mother to fetus through the
placenta. Due to the lack of desaturase activity and the low
level of fetal enzyme activity in the placenta, the fetus re-
quires placental transfer of LC-PUFAs. Fatty acid trans-
porters, binding proteins, and lipolytic enzymes are
responsible for DHA transfer through the placenta to the
fetus [23]. In particular, during the last trimester of the
pregnancy, LC-PUFAs are required for rapid brain develop-
ment; thus, optimum development cannot be achieved in
premature births [1]. Observational studies have shown that
mothers that consumed low amounts of fish during preg-
nancy had children with higher risks of cognitive and be-
havioral problems [26, 27]. Similarly, low blood DHA levels
in newborns have been associated with low visual and
neural maturity [28].
A minimum intake of 160 mg DHA per day increased
newborn and maternal DHA levels, and positively af-
fected the development of the central nervous system [2].
In a study conducted with rats, it was determined that
supplying about 2.5 % of the energy from n-3 fatty acids
(compared to 0.6-1.2 %) positively affected brain develop-
ment [29]. In addition, a different study showed that, dur-
ing pregnancy and lactation in rats, both excessive (7 % of
the energy) and insufficient (0 %) n-3 intakes resulted in
growth deficiencies [30]. Moreover, it was shown that in-
creasing peroxisome proliferator-activated receptor-gamma
by consuming n-6/n-3 PUFAs in a ratio of approximately
1-2:1 would be beneficial to brain development [29].
Intrauterine growth retardation results in a low birth
weight. A low birth weight is known to have important ef-
fects on a child’s growth, development, and health status in
later life. Newborns with low birth weights run increased
risks of morbidity and mortality in the short term [31] and
increased risks of metabolic and cardiovascular diseases in
the long term [11–14]. In particular, due to the important
effects of fatty acids on fetal growth and development, ma-
ternal intake of fatty acids is significantly important for
maintaining fetal health [2, 5]. Changes in the metabolic en-
vironment, due to insufficient or excessive maternal nutri-
ent intake, can cause cell division, cell differentiation, and
programming of cellular responses in the offspring [2].
Fatty acids have important functions in membrane phos-
pholipids. Additionally, fatty acids play complex roles in the
formation of transcription factors and receptors that regu-
late gene expression. Furthermore, fatty acids provide extra-
and intra-cellular communication and serve as a precursor
to eicosanoids. Therefore, fatty acids play important roles
in growth and development. Imbalances in fatty acid intake
during fetal development alter fatty acid levels in mem-
brane phospholipids and stored triglycerides, therefore dis-
rupt the cellular environment and cause structural and
functional programming [5].
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The composition of fats consumed for maternal nutrition
affects the properties of the fatty acids that pass through
the placenta or are secreted in the breast milk. Thus, it is
important to understand the properties of dietary fats [4].
During pregnancy, metabolic changes occur in lipid me-
tabolism and the circulating levels of triglycerides, choles-
terol, fatty acids, and phospholipids. These changes with
insulin resistance and estrogen stimulation contribute to
hyperlipidemia, hyperphagia, lipogenesis, and increases in
fat mass and body weight in the 1st and 2nd trimesters.
Maternal fat accumulation also causes changes in fetal
metabolism, growth, and development. On the other hand,
in the 3rd trimester, catabolic lipase activity arises as a re-
sult of an increase in lipolytic activity in adipose tissue and
a decrease in adipose tissue lipoprotein lipase activity.
These changes in catabolic status result in increases in
triglyceride, phospholipid, and cholesterol levels. The
increase in cholesterol and free fatty acids results in
negative effects on fetal metabolism, and it also alters
the synthesis of cell membranes and steroid hormones
[31]. Thus, changes in nutrients that pass through the
placenta can affect fetal metabolism, growth, and devel-
opment [32, 33].
Essential fatty acids, triglycerides, and lipoproteins con-
sumed during pregnancy reach the fetus by passing through
the placenta via special receptors. Upon transfer to the
fetus, they bind to alpha-fetoproteins and enter the fetal
liver for the synthesis of triglycerides [32]. As mentioned
above, the transfer of PUFA/LC-PUFAs is associated with
the amounts of maternal fat and maternal intake of fatty
acids; additionally, this transfer is affected by placental func-
tion and physiological and biochemical processes that arise
throughout pregnancy [33–35].
Fatty acids consumed by the mother affect the fatty acid
compositions of lipids in fetal blood and newborn blood; in
addition, they affect the developing tissues, and cause differ-
entiation in organs and cells. Due to the fact that excessive
energy and fat consumption have effects on chronic dis-
eases, the amounts of total fat, saturated fat, and n-6 fatty
acids consumed by the mother during the fetal period are
considered among factors that affect fetal programming. It
was proposed that the most important risk factor associ-
ated with fatty acids is excessive n-6 fatty acid intake and
insufficient n-3 fatty acid intake [5].
As a result of excessive maternal n-6 fatty acid intake, re-
duced amounts of n-3 fatty acids, like oleic acid and DHA,
are passed to the fetus. Trans fatty acids, found in hydroge-
nated vegetable oils, are also a part of modern nutrition,
and they affect the developing fetus and the health of the
newborn baby [36]. Trans fatty acids cause increases in oxi-
dative stress and inflammatory cytokines, which affect
metabolic programming. Therefore, when consuminghydrogenated fatty acids, it should be kept in mind, par-
ticularly by pregnant women, that they have negative ef-
fects on the development of the fetus [10].
Fetal metabolic programming
Fetal programming implies that during critical periods of
prenatal growth, permanent changes in molecular, cellular,
metabolic, neuroendocrine, and physiological systems result
from adverse intrauterine conditions. These changes, may
have long-term consequences to increase the individual's
risk for developing adult life diseases. Epidemiological and
animal studies have highlighted the link between alterations
in the early nutritional environment and increased risk of
obesity and metabolic disorders in later life [11–14].
The effect of the fetal period on chronic adult diseases
was explained by Barker and Hales [37], who hypothe-
sized that, of all the environmental factors encountered
during the early stages of development, nutritional sta-
tus, in particular, can increase the risk of adult-onset
metabolic and cardiovascular diseases [38].
This hypothesis about the fetal period is based on the
thrifty genotype hypothesis set forth by Neel [39] in
1962. According to Neel [39, 40], thrifty genes have the
ability to store fat by producing more insulin during
period of famine, when nutrients are limited, but this
situation increases the risks of insulin resistance and
type 2 diabetes. A study by Barker and Hales [37] sup-
ported the thrifty phenotype hypothesis, when they de-
termined that the development of important organs
during the fetal period changed by adapting to a state of
limited nutrients. This change ensured survival in a
nutrient-deficient environment during postnatal life.
However, when abundant nutrients are encountered
after birth, long term harmful effects occur due to the
incompatibility between prenatal and postnatal environ-
ments [41–43].
An absence of nutrients in the intrauterine environ-
ment causes problems, like reduced numbers of neph-
rons, heart muscle cells, and pancreatic cells. As a result,
the functional capacities of these organs are inadequate
throughout the life. It is thought that reductions in cell
numbers and functional capacities occur as a result of re-
duced energy density passing through the placenta; thus,
they represent adaptations aimed to protect the develop-
ment of important vital organs, like the brain [9, 11].
Barker and Osmond [44], conducted a study with 16,000
people and determined that low birth weight was associ-
ated with increased risks of diseases, like coronary heart
disease, hypertension, and type 2 diabetes. Low birth
weight results from insufficient nutrition; thus, inside the
uterus, vital fetal organs become conditioned for a
nutrient-deficient environment. Thus, it is thought that
encountering a different environment after birth increases
the risks of chronic diseases [41–44].
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expression throughout development. Epigenetic modifica-
tions in regulatory genes and growth-related genes play a
significant role in fetal programming. Differences in fetal
gene expression inside the uterus can cause epigenetic
modifications [45]. Epigenetic modifications that involve
gene regulation can cause changes in organ structures, cell
numbers, and metabolism. Additionally, epigenetic modifi-
cations can involve a number of processes, like apoptosis,
that affect growth and development [46, 47]. Moreover, it
was noted that endocrine responses involved in prenatal
development are affected significantly by nutritional status.
During the prenatal stage, many hormone signaling path-
ways are affected, and tissue sensitivities to a variety of
hormones change. Thus, during the development process,
permanent changes can occur [48].
In the past, the effect of insufficient maternal nutrition
on adulthood chronic diseases was emphasized; however,
currently, it is thought that maternal obesity poses a higher
risk to the offspring [8, 49]. Maternal obesity, gestational
diabetes, and preeclampsia can cause changes in fetal
growth and development, similar to those caused by
mother-related insufficient nutrition, placenta-related dys-
function, mother-related stress, and other environmental
influences (infections, alcohol, tobacco) [9, 49]. Therefore,
both low and high birth weights may generate physio-
logical and/or metabolic adaptations in primary vital or-
gans (brain) and other important organs (pancreas,
kidneys, muscles, and liver) [49–51].
Fatty acids and metabolic programming
It is indisputable that excessive energy intake can cause
obesity, and both maternal and adolescence obesity are
increasingly becoming issues [52, 53]. It was mentioned
that metabolic stress factors encountered during both
prenatal and postnatal stages can affect health in later
life. For example, maternal obesity or diabetes during
pregnancy or lactation, low birth weight, and rapid
weight gain in preterm babies are factors associated with
obesity, glucose intolerance, insulin resistance, dyslipid-
emia, and high blood pressure. Studies conducted with
animals have shown that excessive intakes of fat, satu-
rated fat, and carbohydrates or low intakes of protein
and vitamins during pregnancy and lactation can lead to
increased risk of metabolic syndrome [10–14].
Fatty acids are affected by maternal nutrition; they pass
through the placenta or breast milk and accumulate in the
fetus or newborn, respectively [4]. In prenatal and postna-
tal stages, fatty acids and metabolites play an important role
in cell enlargement and differentiation, and they regulate
cellular responses between metabolic and neuroendocrine
environments [2]. Although fatty acids are mainly found in
the phospholipids of cell membranes, they also contribute
to the molecular signals that govern appetite and energymetabolism. In addition, fatty acids act as metabolic sensors
that participate in the regulation of genes involved in en-
ergy oxidation and storage. Therefore, it is thought that in-
sufficient, imbalanced, or excessive fatty acid intake in the
early stages of development can also contribute to meta-
bolic programming [5]. In a study that included 150 preg-
nant women with gestational diabetes, but with controlled
blood sugar, a correlation was found between serum free
fatty acid levels and fetal fat mass in the 3rd trimester. It
was suggested that this condition could cause long term ef-
fects on health (e.g., dyslipidemia, hypertension, insulin re-
sistance, and obesity) [54].
Changes in nutrition affect the endocrine system, which,
in turn, causes disruptions in appetite mechanisms and en-
ergy balance. Inappropriate metabolic and endocrine re-
sponses occur in organs like brain, adipose tissue, muscle,
liver, and pancreas [14]. Although the mechanisms that give
rise to these inappropriate organ responses are not com-
pletely understood, it is thought that structural changes in
the cells and organs occur due to changes in metabolic and
neuroendocrine signaling, gene expression, and epigenetic
mechanisms [5, 55]. For example, epigenetic modifications,
like DNA methylation and histone modification play key
roles in biological processes involved in intrauterine devel-
opment, including gene expression, chromatin accessibil-
ity, and DNA replication. These processes are important
in forming, protecting, and transferring phenotypes to the
next generation [10, 11]. DNA methylation is affected by
factors associated with nutrition. Methylation of some
genes is initiated by metabolic and neuroendocrine events.
It is thought that those genes are responsible for epigen-
etic programming, depending on the conditions in nutri-
tional or endocrine environments [11]. It is also thought
that maternal fatty acid intake can cause epigenetic modi-
fications [10].
In recent years, studies on metabolic programming have
focused on excessive maternal nutrition. These research
studies involved women that were overweight or obese dur-
ing pregnancy. With increases in maternal body weight and
triglyceride levels, there is an increase in maternal fatty acid
transfer, which affects the body weight, adiposity, inflamma-
tory cytokines, and leptin levels of the newborn infant. All
these factors prepare the ground for the development of
hyperphagia, insulin resistance, obesity, and type 2 diabetes
[8, 49, 56]. Studies conducted with animals showed that
high fat or high carbohydrate intakes during pregnancy or
lactation caused increased lipid accumulation in muscles,
adipose tissue, and liver of the offspring and changes in
hepatic gene expression, pancreatic beta cell development,
and insulin and leptin secretions [56–61].
In a study conducted with rats during pregnancy and
lactation, one group was fed a normal diet and another
group was fed a diet with 30 % less energy than normal.
The offspring born after insufficient gestational nutrition
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from fats. In that group, the average daily energy intake per
body weight was increased and, when the offspring reached
100 days old, their systolic blood pressure and blood insulin
levels were elevated [58]. In a different study conducted
with female rats, during the 120 days prior to pregnancy,
one group was fed a diet with 59.5 % of the energy from
fats (high fat), and another group was fed a diet with 10.9 %
of the energy from fats (standard diet). On the 21st day of
gestation, compared to the standard diet group, the high fat
diet group was 20 % heavier, consumed more energy, and
had twice insulin, 34 % more glucose, and 68 % more tri-
glycerides in their blood. In a continuation of the study,
aimed at investigating the effects of hypercaloric nutrition,
they tested male rats born to the mothers fed a high fat
diet. After the lactation period, one group was fed standard
nutrition, and another group was fed a high sucrose (67 %
carbohydrate, 7 % fat, and 18 % protein) diet. Compared to
the standard nutrition group, the group fed a high sucrose
diet (after a high fat intake during pregnancy and lactation)
exhibited elevations in body weight, plasma triglycerides,
free fatty acids, and insulin levels. Hence, this condition
caused metabolic problems [59].
In a study hypotesised that high-fat feeding during
pregnancy is associated with a programming effect on
the liver. It was concluded that maternal high-fat diet
feeding during pregnancy programs liver which strongly
modulates glucose homeostasis and organ fat accumula-
tion in adult life after exposure to a nutritional insult
[61]. High fat or high sugar diets consumed during the
perinatal stage can cause permanent changes in metab-
olism and lead to excessive consumption of appetizing
foods. Another study investigated the effects of junk
food-type maternal nutrition during pregnancy and lac-
tation stages on 6-week to 3-month old rats. They deter-
mined that rats born to mothers fed junk food had
higher fat consumptions compared to those born to
mothers fed a standard diet [60].
Similar to the amount of total fat intake, the type of
fatty acid consumed also has effects on organ devel-
opment and metabolic programming [62–64]. In a
study conducted with rats, a diet containing 18 % fat
was fed to pregnant rats for 2 weeks. One group was
given coconut oil (saturated fatty acid), another group
was given fish oil (unsaturated fatty acid), and a third
group was given soy oil (control group). The effects of
fatty acids on the health of the newborn were investi-
gated. That study determined that the offspring of
mothers fed unsaturated fats had lower birth weights
and slower weight gain after birth than offspring from
the other groups. The offspring from mothers fed satu-
rated fats exhibited low numbers of pancreatic islets and
a rapid, high insulin response on the oral glucose toler-
ance test. Therefore, it was determined that the type offatty acids consumed during pregnancy could have ef-
fects on the growth, pancreatic development, and glu-
cose metabolism of the newborn [62].
In a study conducted with rats, hydrogenated vege-
table oils, palm oil, canola oil, and soy oil were used to
determine the effects of different fatty acids on adiposity
and blood lipids. The four groups of fatty acid composi-
tions were fed to mothers during pregnancy and to the
offspring after birth, for 21 days during and 45 days after
the lactation stage. The results showed that the offspring
in the palm and hydrogenated vegetable oil groups had
higher body weights than those in the canola and soy oil
groups. Furthermore, the hydrogenated vegetable oil
group exhibited higher triglyceride and total cholesterol
levels than those of the palm oil group, and lower HDL
cholesterol levels than those of the other 3 groups [64].
It was observed that, as a result of the energy, total fat,
and fatty acid intakes of the mother during pregnancy
and lactation, metabolic programming could be caused
in many organs of the offspring, including adipose tissue,
muscle tissue, liver, and pancreas. These changes in
main vital organs indicated that the incompatibility be-
tween the early stage food substrates and the endocrine
environment can cause permanent changes due to pro-
gramming of hypothalamic signaling, appetite, and en-
ergy balance [5]. These studies provided important
information about the potential long term effects of a
high fat maternal diet or maternal consumption of dif-
ferent types of fatty acids on the metabolic programming
of offspring [58–63].
Discussion
It is claimed that the fetal environment has effects on
hypothalamic and brain functions that involve appetite
control, energy balance, and obesity [65, 66]. Brain devel-
opment starts during the development of the embryo
and continues after birth [6]. Brain development has ef-
fects on critical developmental stages, like cell prolifera-
tion, transport, differentiation, axon development,
synaptogenesis, and apoptosis. Disruption of hypothal-
amic development during critical development stages
causes serious structural and functional anomalies in the
hypothalamus [67].
The hypothalamus combines endocrine, metabolic,
and neural signals to form behavioral, anatomic, and
endocrine responses, and hence, provides appetite con-
trol [6]. Animal experiments have shown that maternal
obesity can cause programming of hypothalamic appetite
control. High fat nutrition during pregnancy and lacta-
tion causes hyperphagia and obesity in the offspring, and
it disrupts hypothalamic gene expression [18, 68]. A
study conducted with mice showed that differences in
prenatal and postnatal nutrition, particularly insufficient
prenatal protein intake combined with high fat postnatal
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cessive nutrient intake [69].
Regulation of energy balance and appetite is complex. It
involves balancing the important orexigenic neuropeptides,
like neuropeptide Y (NPY) and agouti-related peptide
(AgRP), and anorexigenic peptides, like proopiomelano-
cortin (POMC) and cocaine and amphetamine regulating
transcript (CART). Additionally, hypothalamic control is
affected by hormones secreted from the adipose tissue,
pancreas, and intestines [6, 11]. Leptin, secreted by adi-
pose tissues, and insulin, secreted by the pancreas, are
among the most important hormones that regulate energy
balance. When these hormones penetrate the blood–brain
barrier, neural signals in the acute nucleus part of the
hypothalamus also take part in regulating energy balance.
NPY, AgRP, and POMC are produced by acute neurons.
Leptin and insulin directly target AgRP, NPY, and POMC
production; they activate POMC neurons and block NPY
neurons. These actions cause a reduction in nutrient in-
take and an increase in energy consumption [70].
During the early stages of development, changes in the
signals from leptin and insulin alter the development of
neuro-regulatory signals that control eating behavior. It
is thought that these changes may be responsible for hy-
perphagia or excessive weight gain in later life. It was
shown that a maternal high fat diet caused changes in
hypothalamic peptides, like POMC and AgRP, in the fetal
brain [71, 72]. In an experimental study, it was determined
that high fat maternal nutrition caused leptin resistance in
the offspring. The development of leptin resistance, hyper-
phagia, and increased adiposity cause increases in the risk
of adult obesity [18]. Additionally, maternal obesity and
increased food intake disrupt glucose metabolism, and
raise insulin resistance in the offspring; this increases the
risks of adiposity and obesity [8, 73].
The melanocortin system in the hypothalamus also
plays a vital role in regulating energy balance and body
weight. Melanocortins are anorexic neuropeptides pro-
duced from the POMC gene. AgRP, on the other hand,
works in opposition to the melanocortin system and
stimulates appetite [72]. It is known that mutations in
melanocortin receptors cause hyperphagia and obesity in
mice and humans [74, 75]. High fat maternal diet and
maternal obesity cause fetal and neonatal liver lipotoxi-
city [8, 76]. Moreover, high fat maternal nutrition in-
creases inflammatory cytokines in offspring [72]. Both
high fat nutrition and elevated inflammatory cytokines
affect the melanocortin system [72, 77].
The hypothalamic melanocortin system, which con-
trols appetite and energy consumption, develops during
the last trimester. Maternal nutrition and the health of
the mother have important effects on the development
of the melanocortin system. A study was conducted with
female monkeys to investigate the effects of high fatmaternal nutrition during pregnancy on the develop-
ment of the melanocortin system in offspring. The mon-
keys were fed a high fat (35 % fat, peanut oil) or
controlled (13 % fat) nutrition diet for up to 4 years; dur-
ing that time they became pregnant, and the fetuses
were examined in the 3rd trimester. One group of mon-
keys on the high fat diet were switched to the controlled
diet in the 5th year; during that time they became preg-
nant. Compared to fetuses from the controlled diet
group, those from the high fat group showed higher
POMC mRNA expression and lower AgRP mRNA ex-
pression. Additionally, they found increased levels of
proinflammatory cytokines including IL-1β and IL-1
type 1 receptors in the hypothalamus. The offspring of
the monkeys that switched to a controlled diet during
the 5th year had normal melanocortin levels. Independ-
ent of maternal obesity and diabetes, high fat nutrition
during pregnancy can cause activation of proinflamma-
tory cytokines, which can change the development of
the melanocortin system. When fetal POMC system
anomalies continue during the postnatal stage, a variety
of body systems may be affected, including body weight
maintenance, stress responses, and cardiovascular func-
tions. Moreover, a high fat diet causes the offspring to
gain excessive weight at an early stage. These anomalies
can be prevented in the offspring by sufficient, balanced
nutrition in pregnant women, regardless of obesity or
serious insulin resistance [72].
Dietary lipids affect the fatty acids present in neuronal
membranes, some neurotransmitters, and lipid-like sig-
naling molecules. Thus, changes in programming can
affect adipose tissue mass, compositions of lipids, and
metabolism [5]. A study conducted recently on rats in-
vestigated fat mass accumulation over 4 generations
when the diet included 35 % of the energy from fats
(18 % linoleic and 0.6 % alpha-linoleic, 28:1). They found
that, although food consumption remained the same in
each generation, adipose tissue mass, hyperplasia, and
hypertrophy gradually increased over 4 generations.
Moreover, it was observed that, over the 4 generations,
adipokine levels changed, adipose tissue gene expression
changed, and hyperinsulinemia developed. Considering
all these changes, it is reasonable to hypothesize that the
modern increase in obesity may be associated with ex-
cessive linoleic acid intake [78].
In another study, the adiposity status of 3 year-old
children was compared with fatty acid intake during the
2nd trimester of pregnancy. They measured total skin
fold thickness of the triceps and subscapula. Those au-
thors could not find a significant relationship between
the maternal eicosapentaenoic acid (EPA) + DHA plasma
concentration during pregnancy and the adiposity of
their children. However, they found that increases in the
n-6/n-3 ratio in the maternal diet were related to
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was determined that insufficient n-3 intake during preg-
nancy may be a risk factor for childhood obesity [79]. In
addition, a recent study determined that a higher intake
of n-6 fatty acids compared to n-3 fatty acids was associ-
ated with increased adipogenesis [78]. Another study
showed that a high n-6/n-3 intake during pregnancy
caused an increase in the number of fat cells of the de-
veloping fetus; consequently, the n-6/n-3 ratio is consid-
ered a risk factor for childhood obesity [80]. It was
determined that DHA prevented adipocyte differenti-
ation, initiated apoptosis in preadipocytes, and increased
lipolysis in adipocytes; these activities were expected to
create a protective effect against obesity [81]. In a differ-
ent study, it was stated that, particularly in perinatal
stages, n-3 fatty acids can play a role in regulating appe-
tite signals, and they can affect the normal development
of food intake mechanisms [82]. A systematic evaluation
of the results from animal studies on how maternal n-3
LC-PUFA supplementation affected the body mass of
offspring emphasized that more research is needed on
this subject [83]. Although, several studies have shown
that n-3 fatty acid intake during pregnancy has a pro-
tective effect against obesity, more studies are needed to
confirm the results.
When the effects of fatty acids on body functions are
considered from all different aspects, it can be claimed
that they have an effect on metabolic programming. Sat-
urated fats, n-3 fatty acids, and n-6 fatty acids have dif-
ferent effects on lipid metabolism [84]. In the liver, fatty
acids regulate the expression of key lipogenic, lipolytic
and glycolytic genes [21]. Fatty acids or metabolites affect
transcription factors that regulate the expression of en-
zymes that regulate gluconeogenesis, glycolysis, fatty acid
synthesis, and fatty acid oxidation [84]. Micronutrients,
like folic acid and vitamin B12, also have effects on fatty
acid metabolism, and these are considered nutritional fac-
tors that can influence metabolic programming [85].
Based on all these metabolic processes, it is clear that
fatty acids, particularly n-6 and n-3 fatty acids, can have
effects on fetal programming. The effects of these fatty
acids on fetal programming are transmitted in their roles
as bioactive compounds, in cell differentiation, in meta-
bolic signal regulation, in energy balance mechanisms, and
their potential functions in other physiological processes.
Conclusion
This review discussed a variety of hypotheses on meta-
bolic programming. We emphasized the effects of ma-
ternal fatty acid intake on fetal development by detailing
the primary functions of fatty acids on growth and de-
velopment. The facts that fatty acids are a main energy
source, play key roles in metabolic processes, and have
important functions on appetite and energy balance,indicate that they can affect the metabolic programming
of obesity and other chronic diseases.
Currently, coincident increases in the frequency of
metabolic diseases and consumption of n-6 fatty acids
have called attention to the point that fatty acids may
have effects on metabolic diseases. Although insufficient
evidence exists to support this point, studies with ani-
mals have suggested that fatty acids may have important
effects on human health. Fatty acids contribute to com-
plex mechanisms, affect multiple tissues, and take part
in multiple metabolic processes.
The Institute of Medicine (IOM) recommends the
consumption of 200-300 mg/day DHA from seafood
during pregnancy and lactation. To meet these recom-
mendations, an average of 340 g/week of fish should be
consumed. Swordfish, shark, and large mackerel should be
avoided, because they may contain methyl-mercury [86].
Excessive or insufficient fatty acid intake during the pre-
natal and postnatal stages cause metabolic and endocrine
adaptations that affect cell division, cell differentiation,
gene expression, and epigenetic modifications. All these
changes can, through developmental programming, cause
permanent changes in body composition, adipose tissue,
vital organs (like brain and liver), and metabolic and neu-
roendocrine systems. The studies discussed here were fo-
cused on excessive and high fat maternal nutrition, and
the general properties of fatty acids were put into the con-
text of their potential effects on energy balance. In future,
long term observational studies are needed to determine
the effects of fatty acids on fetal programming.
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